Skip to main content

Find Clinical Trials

Home
Conditions
Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)

Clinical trial condition

Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)

Explore clinical trials studying Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL). Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL) trial results

Recruiting

Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma

NCT06909877

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Sichuan Cancer Hospital Chengdu, China

View Trial Details

Recruiting

A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL

NCT06855823

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details